Iran’s rapid progress in medical sciences, particularly in bone marrow transplantation, highlights the country’s self-sufficiency in cutting-edge treatments and its ability to provide life-saving medical solutions at a global scale.

What he's saying:

Mostafa Ghanei, Secretary of the Biotechnology, Health, and Medical Technologies Headquarters, stated during the unveiling ceremony of the "Destrosel" drug: "Iran is one of the leading countries in the region for bone marrow transplantation, maintaining a considerable lead over neighboring nations in transplantation statistics."
 

Key points:

• Iranian specialists have achieved breakthroughs in treating leukemia, lymphoma, multiple myeloma, and immune disorders through transplantation.
• A knowledge-based Iranian company has developed "Destrosel," an allogeneic cell therapy drug that significantly reduces GVHD (Graft-versus-host disease), a major post-transplant complication.
• Iran has outpaced other regional nations in the number and success rate of bone marrow transplants.

Go deeper:

Iran's progress in bone marrow transplantation is part of its strategy for self-reliance in medical sciences, aiming to reduce dependence on foreign pharmaceuticals and improve healthcare access. This focus on domestic innovations reinforces its role as a regional healthcare leader.